Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.

Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer. PLoS One (2017) 0.75

Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72

Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet (2012) 8.55

Akt-regulated pathways in prostate cancer. Oncogene (2005) 3.35

Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene (2010) 2.22

Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene (2006) 2.07

Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res (2009) 1.70

Activation of an olfactory receptor inhibits proliferation of prostate cancer cells. J Biol Chem (2009) 1.67

Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. Endocr Relat Cancer (2013) 1.57

PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res (2000) 1.57

Role of the p70(S6K) pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res (2004) 1.49

Real-time visualization of a fluorescent G(alpha)(s): dissociation of the activated G protein from plasma membrane. Mol Pharmacol (2002) 1.30

Cooperative regulation of p70S6 kinase by receptor tyrosine kinases and G protein-coupled receptors augments airway smooth muscle growth. Biochemistry (2005) 1.23

Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets. Acta Pharmacol Sin (2012) 1.17

Promotion of cancer cell invasiveness and metastasis emergence caused by olfactory receptor stimulation. PLoS One (2014) 1.09

Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers. Int J Cancer (2005) 1.01

The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Prostate (2006) 1.00

Quantitative expression profile of PSGR in prostate cancer. Prostate Cancer Prostatic Dis (2006) 1.00

PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine. Prostate (2010) 0.97

MACC1 is related to colorectal cancer initiation and early-stage invasive growth. Am J Clin Pathol (2013) 0.95

Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene (2001) 0.94

Cloning and genetic characterization of an evolutionarily conserved human olfactory receptor that is differentially expressed across species. Gene (2001) 0.94

Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells. Neoplasia (2008) 0.94

Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab. Clin Cancer Res (2011) 0.93

A three-gene panel on urine increases PSA specificity in the detection of prostate cancer. Prostate (2011) 0.93

N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth. PLoS One (2012) 0.93

G protein-coupled receptor signaling via Src kinase induces endogenous human transient receptor potential vanilloid type 6 (TRPV6) channel activation. J Biol Chem (2011) 0.87

Perspectives on mTOR inhibitors for castration-refractory prostate cancer. Curr Cancer Drug Targets (2012) 0.84

Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung. Mod Pathol (2012) 0.79